http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2674704-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ed0ec697e4724f27758e484d746ea5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-236 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-02 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 |
| filingDate | 2016-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_419e57eed736381222725992e7ba5f55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b721f7f8e543c19e5896527e7be9f49f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d72213375e0e7478edc3c5a5eafe8fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78f33227e38820be6f2b5060d2e31ea5 |
| publicationDate | 2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2674704-C1 |
| titleOfInvention | Haemostatic injection needle with coating from cross-linked chitosan containing pyrocatechine group and oxidated pyrocatechine group |
| abstract | FIELD: medicine.SUBSTANCE: group of inventions relates to a hemostatic injection needle, to the method of its manufacture, to a method of performing a hemostatic injection and a hydrogel for coating a injection needle that prevents blood loss during the injection, which contains chitosan with a pyrocatechine group introduced into it, in which the –OH group of the pyrocatechol group of the hydrogel is partially oxidized to the =O group, and then crosslinked by the dehydration-condensation reaction with -NHgroup contained in chitosan, the percentage of oxidation of the pyrocatechol group is from 1 to 20 % (molar ratio) of the pyrocatechol groups contained in the hydrogel.EFFECT: group of inventions provides effective suppression of blood loss during and after the injection.8 cl, 5 dwg, 2 ex |
| priorityDate | 2015-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.